Clinical trial
The Metabolic and Glycaemic Responses to Reductions in Rapid-acting Insulin Dose After Running Exercise in People With Type 1 Diabetes Mellitus.
NCT01531855 is registered in ClinicalTrials.gov with Northumbria University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Metabolic and Glycaemic Responses to Reductions in Rapid-acting Insulin Dose After Running Exercise in People With Type 1 Diabetes Mellitus.
- Lead sponsor
- Northumbria University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- August 31, 2012
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes